Informatie:
Fout:
ID
34587
Beschrijving
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled; ODM derived from: https://clinicaltrials.gov/show/NCT01699932
Link
https://clinicaltrials.gov/show/NCT01699932
Trefwoorden
Versies (1)
- 19-01-19 19-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
19 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Type 2 Diabetes Mellitus NCT01699932
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients with type 2 diabetes mellitus inadequately controlled despite a treatment with sulfonylurea (su) alone or metformin alone or a free combination of su and metformin prior to the study entry.
boolean
ID.2
Item
signed informed consent, obtained prior any study procedure
boolean
ID.3
Item
age < legal age of adulthood
boolean
ID.4
Item
hba1c < 7% or ≥ 11%
boolean
ID.5
Item
bmi > 35 kg/m2
boolean
ID.6
Item
treatment with a stable dose of maximally tolerated su alone or metformin alone or the free combination of su and metformin for less than 12 weeks prior to the screening visit.
boolean
ID.7
Item
patients who received any anti-diabetic drug other than su or metformin within 12 weeks prior to the screening visit.
boolean
ID.8
Item
diabetes other than type 2 diabetes (e.g. type 1 diabetes, diabetes secondary to pancreatic disorders, drug or chemical agent intake…)
boolean
ID.9
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean